Skip to main content
ResMed Inc. (RSMDF)
OTCMKTS · Delayed Price · Currency is USD
22.00
0.00 (0.00%)
Jun 25, 2025, 8:00 PM EDT

ResMed Revenue

ResMed had revenue of $1.29B in the quarter ending March 31, 2025, with 7.92% growth. This brings the company's revenue in the last twelve months to $5.02B, up 9.54% year-over-year. In the fiscal year ending June 30, 2024, ResMed had annual revenue of $4.69B with 10.95% growth.

Revenue (ttm)
5.02B
Revenue Growth
+9.54%
P/S Ratio
7.47
Revenue / Employee
503.16K
Employees
9,980
Market Cap
37.50B

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Jun 30, 20244.69B462.30M10.95%
Jun 30, 20234.22B644.87M18.02%
Jun 30, 20223.58B381.30M11.93%
Jun 30, 20213.20B239.81M8.11%
Jun 30, 20202.96B350.44M13.44%
Jun 30, 2019 Pro Pro Pro
Jun 30, 2018 Pro Pro Pro
Jun 30, 2017 Pro Pro Pro
Jun 30, 2016 Pro Pro Pro
Jun 30, 2015 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Endo, Inc. 1.73B
Elite Pharmaceuticals 70.00M
Veradigm 588.02M
Tian'an Technology Group 1.78M
American Oncology Network 1.76B
Glass House Brands 215.62M
Northwest Biotherapeutics 1.47M
Silence Therapeutics 27.70M
Revenue Rankings

ResMed News

More News